BETH ISRAEL DEACONESS DEPARTMENT O… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

DEWAYNE PURSLEY MD

Phone

6176673276

Tax Period

2023-10-01 to 2024-09-30

BETH ISRAEL DEACONESS DEPARTMENT OF NEONATOLOGY FOUNDATION INC, founded in 2007, is a micro nonprofit in the Medical Research sector that reported $89K in total revenue in fiscal year 2023. Revenue surged 219% from the prior year, signaling strong growth momentum. The organization ran a surplus of $71K, a strong 79% operating margin.

Mission

THE MISSION OF BETH ISRAEL DEACONESS DEPARTMENT OF NEONATOLOGY FOUNDATION, INC. (THE FOUNDATION) IS TO SUPPORT THE PATIENT CARE, RESEARCH, AND TEACHING MISSIONS OF BETH ISRAEL DEACONESS MEDICAL CENTER (BIDMC) AND HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER (HMFP) AS WELL AS TO SUPPORT TEACHING AND RESEARCH AT THE PRESIDENT AND FELLOWS AT HARVARD COLLEGE/HARVARD MEDICAL SCHOOL (HMS).

Program Service Accomplishments

Program 1

Expenses: $4,656

DURING THE PERIOD COVERED BY THIS FILING, THE FOUNDATION USES ITS FUNDS TO SUPPORT MEDICAL RESEARCH, PROVIDE INSTRUCTION, AND PARTICIPATE IN ACTIVITIES DESIGNED TO IMPROVE THE GENERAL PUBLIC HEALTH OF PATIENTS SERVED BY BETH ISRAEL DEACONESS MEDICAL CENTER (BIDMC), HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER (HMFP) AND THEIR AFFILIATES. THE FOUNDATION USES ITS FUNDS TO SUPPORT THE PHYSICIANS' WORK IN THE NEONATOLOGY DEPARTMENTS AT BIDMC AND HMFP AND TO STRENGTHEN THE DEPARTMENT BY SUPPORTING THE EDUCATIONAL REQUIREMENTS OF THE DEPARTMENT AND PHYSICIANS WORLDWIDE BY PROVIDING TRAINING SEMINARS AND OTHER CLASSES. THE FOUNDATION ALSO USES ITS FUNDS TO SUPPORT EXPENSES INCURRED BY ITS AFFILIATED ENTITIES WHICH BENEFIT THE PHYSICIANS AND OTHER PERSONNEL WHO ARE ENGAGED IN ACTIVITY RELATED TO THE NEONATOLOGY FIELD. ALL ACTIVITIES THAT THE FOUNDATION PARTICIPATES IN ARE FOCUSED ON MEDICAL PROCEDURES, RESEARCH, AND OTHER ACTIVITIES THAT ARE INSPIRED TO ENHANCE METHODS UTILIZED IN THE NEONATOLOGY FIELD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $87,167

Other Revenue $2,271

TOTAL REVENUE $89,438

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $4,656

Other Expenses $18,931

TOTAL EXPENSES $18,931

Year-over-Year Comparison

	2023	2022	Change
Revenue	$89,438	$28,052	+2.2%
Expenses	$18,931	$30,389	-0.4%
Net Income	$70,507	$-2,337	-31.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,574,044

Total Directors

$2,949,137

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KIMBALL MD MPH ALEXA B	DIRECTOR (EX-OFFICIO) (HMFP CEO)	1.00	Director	$0	$109,829	$1,199,659
PURSLEY MD DEWAYNE M	DIR(EXO)&PRES; NEONATOLOGY CHIEF/CHR	1.00	Officer Director	$0	$94,138	$856,000
ZUPANCIC MD JOHN A	DIR&TREAS (ASSOC CHIEF NEONAT BIDMC)	1.00	Officer Director	$0	$116,229	$629,367
BRODSKY MD DARA	DIR & SEC (NEONATOLOGIST, HMFP)	1.00	Officer Director	$0	$75,639	$264,111
ROSENBERG MD STUART A	DIRECTOR	1.00	Director	$0	$0	$0
AGNEW MEGHAN	CO-CLERK; CFO, HFMP	1.00	Officer	$0	$89,105	$518,759
DALTON MEGHAN	CO-CLERK & CHIEF ADMINISTRATIVE OFF	1.00	Officer	$0	$84,120	$305,807

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$89,438	$18,931	$2,812,694	$70,507
2023	$28,052	$30,389	$2,553,500	$-2,337
2022	$43,448	$18,023	$2,431,605	$25,425
2021	$115,228	$26,421	$2,490,576	$88,807
2020	$43,244	$44,886	$1,647,488	$-1,642
2019	$42,049	$19,393	$1,657,278	$22,656
2018	$38,584	$13,763	$1,033,281	$24,821

BETH ISRAEL DEACONESS DEPARTMENT OF NEONATOLOGY FOUNDATION INC